Live Breaking News & Updates on ஆற்றல் படிப்பு|Page 3
Stay updated with breaking news from ஆற்றல் படிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Choose wisely : Greta Thunberg warns House lawmakers on their legacies, urges end to fossil fuel subsidies Jeanine Santucci, USA TODAY Replay Video UP NEXT WASHINGTON Teen climate activist Greta Thunberg called tax breaks for the fossil fuel industry a disgrace in testimony to Congress at an Earth Day hearing on subsidies. The 18-year-old activist from Sweden told the House Oversight Committee in the hearing on The Role of Fossil Fuel Subsidies in Preventing Action on the Climate Crisis that history would hold them accountable if they fail to take action to end fossil fuel subsidies, a cause taken up by the progressive wing of the Democratic Party. ....
Greta Thunberg to Congress: Subsidizing Fossil Fuel Industry With Taxpayer Money Is a 'Disgrace' nbcwashington.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcwashington.com Daily Mail and Mail on Sunday newspapers.
Greta Thunberg to Congress: Subsidizing Fossil Fuel Industry With Taxpayer Money Is a 'Disgrace' necn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from necn.com Daily Mail and Mail on Sunday newspapers.
'Choose wisely': Greta Thunberg warns House lawmakers on their legacies, urges end to fossil fuel subsidies msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Janssen Showcases Phase 2 Nipocalimab (M281) Data in Adults with Generalized Myasthenia Gravis (gMG) at the 2021 American Academy of Neurology Virtual Meeting Full results from the Vivacity-MG study to be presented for the first time during an oral presentation News provided by Share this article Share this article TITUSVILLE, N.J., April 16, 2021 /PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the full results from the Phase 2 Vivacity-MG study of the investigational compound, nipocalimab (M281), in generalized myasthenia gravis (gMG)–a chronic, autoimmune neuromuscular disease. The data will be featured as part of an oral presentation at the American Academy of Neurology (AAN) Virtual Meeting taking place April 17-22, 2021. ....